Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Stanford"

16 News Found

First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal
Public Health | April 22, 2022

First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal

The first use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter


HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies
Biotech | April 13, 2022

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies

Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases


Innovative therapy that ‘tricks’ and destroys cancer cells advance to clinical trial
Biotech | April 10, 2022

Innovative therapy that ‘tricks’ and destroys cancer cells advance to clinical trial

Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer


Jubliant FoodWorks leads Rs 11 crore funding in Wellversed
Startup | September 30, 2021

Jubliant FoodWorks leads Rs 11 crore funding in Wellversed

The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent


Visby Medical receives FDA approval and CLIA waiver for PCR sexual health test
Drug Approval | August 30, 2021

Visby Medical receives FDA approval and CLIA waiver for PCR sexual health test

The Visby Medical sexual health click test is the first instrument-free PCR test for the detection of chlamydia, gonorrhoea and trichomonas, with results available within 30 minutes, during the patient visit


Pharma industry bullish on complex generics and biosimilars
News | February 25, 2021

Pharma industry bullish on complex generics and biosimilars

While top industry leaders are optimistic about the growth, they expect the special incentives and regulatory streamlining from the government’s side